We are live on
!
Find out more
Matinas BioPharma
MTNB
MTNB
30 hedge funds and large institutions have $260K invested in Matinas BioPharma in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
7% more funds holding
Funds holding: 28 → 30 (+2)
0.42% more ownership
Funds ownership: 6.49% → 6.91% (+0.42%)
58% less capital invested
Capital invested by funds: $618K → $260K (-$357K)
Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$77.5K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$54.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.9K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.9K |
| 5 |
Jane Street
New York
|
+$18.7K |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
-$42.7K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$28.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$23.7K |
| 4 |
HF
HRT Financial
New York
|
-$20K |
| 5 |
Citigroup
New York
|
-$2.38K |
